Phase 4 Dyslipidemia Clinical Trials
6 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–6 of 6 trials
Recruiting
Phase 4
Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention
Coronary Artery DiseaseDyslipidemiasPrimary Prevention
Saint Vincent's Hospital, Korea6,356 enrolled1 locationNCT06186037
Recruiting
Phase 4
Effect of Ezetimibe on Gut Microbiota
Atherosclerotic Cardiovascular Disease With Dyslipidemia
Yonsei University110 enrolled1 locationNCT06784557
Recruiting
Phase 4
High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium
Metabolic SyndromeDyslipidemiasCoronary Artery Calcification
Samsung Medical Center6,000 enrolled1 locationNCT05845424
Recruiting
Phase 4
CPAP Effect on Lipid Profile and Hyperuricemia in Patients With Dyslipidemia and Moderate-severe Obstructive Sleep Apnea
Sleep ApneaHyperuricemiaDyslipidemias
Hospital Universitario La Paz220 enrolled1 locationNCT06463561
Recruiting
Phase 4
Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
Diabetes Mellitus, Type 2AtherosclerosisDyslipidemias
Seoul National University Bundang Hospital105 enrolled1 locationNCT05365438
Recruiting
Phase 4
Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
Diabetes Mellitus, Type 2AtherosclerosisDyslipidemia
Seoul National University Bundang Hospital56 enrolled1 locationNCT05365425